We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

How Fed. Circ. Guides PTAB On CBM Review: Part 2

Law360, New York (August 8, 2017, 1:06 PM EDT) -- Covered business method reviews are an important component of America Invents Act patent trials, but the extent of patents eligible for CBM review has not been subject to a consistent standard. In the first part of this article, we discussed the Federal Circuit’s decisions narrowing the scope of CBM eligibility, eliminating from CBM review patents claiming activities that are only “incidental to” or “complementary to” financial activity, and its most recent order denying en banc rehearing in Secure Axcess — which may have settled the legal...
To view the full article, register now.